Psychopathology in Patients Diagnosed with Sars Cov 2: a Brief Report

Background: COVID-19 is the newest and one of the most important infectious disease that became a pandemic during last year (2020) and it is caused by SARS-CoV-2 (human coronavirus), which first was diagnosed in Wuhan, China, at the end of 2019 and spreaded globally during 2020 changing our lifestyle worldwide. To evaluate the development risk of psychiatric symptoms in patients who manifested COVID 19 symptoms during the quarantine period acute phase of the disease and the aggravation of some patients` symptoms after this infectious disease. Methods: We have conducted a study on 28 patients diagnosed with SARS-CoV-2 and who have received psychopathological follow up during the quarantine through telemedicine, patients selected for a period of 3 month. Results: The average age of the patients was of 46,89 years old, with an associated standard deviation of 18,68 years and with a predominance in female gender (60,7%). 85,4% of the subjects developed psychopathologies, depending on the type of the experienced quarantine (especially home quarantine – sig = 0,042) or on the presence of sensory disorders as symptomatology (sig.=0,046). Conclusions: Adverse mental health impact has been reported in patients with SARS-CoV-2, that could be related either to the intensity of the COVID 19 symptoms (headache, cough, fever, gastrointestinal disorders, dyspnea, anosmia and ageusia) or to the disruption of personal and social healthcare and lifestyle.